Table 1.
Tests Parameters | Treatment Groups | |||||
---|---|---|---|---|---|---|
Body weight | Treatment Day | NC | DC | LUT | GLB | |
Day 0 | 161.87 ± 4.86 | 164.37 ± 5.24 ns | 160.68 ± 3.73 ns | 161.13 ± 5.94 ns | ||
Day 7 | 171.85 ± 3.27 | 154.78 ± 4.97 ɸ | 164.18 ± 4.21 € | 166.46 ± 3.55 £ | ||
Day 14 | 184.40 ± 3.44 | 141.52 ± 5.85 ɸ | 180.19 ± 5.71 £ | 176.87 ± 5.12 £ | ||
Day 21 | 200.80 ± 3.96 | 132.00 ± 5.96 ɸ | 194.07 ± 4.75 £ | 202. 09 ± 5.02 £ | ||
Lipid profile | TC (mg/dL) | Day 0 | 78.78 ± 2.44 | 183.38 ± 4.42 ɸ | 95.79 ± 3.86 £ | 89.38 ± 3.00 £ |
TG (mg/dL) | Day 7 | 111.75 ± 2.36 | 164.10 ± 2.43 ɸ | 117.13 ± 4.31 € | 107.05 ± 4.40 £ | |
HDL (mg/dL) | Day 14 | 30.14 ± 0.98 | 22.68 ± 1.11 ɸ | 27.34 ± 0.57 € | 27.18 ± 1.21 £ | |
LDL (mg/dL) | Day 21 | 30.40 ± 1.51 | 103.42 ± 2.90 ɸ | 46.95 ± 2.55 £ | 36.51 ± 2.51 £ |
Values indicate mean ± SD (n = 6). $/ϕ p < 0.05, €/ʠ p < 0.01, and £/ɸ p < 0.001, compared with treatment and normal control, respectively. ns = not significant.